Los Angeles Capital Management LLC Acquires New Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR)

Los Angeles Capital Management LLC acquired a new stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 295,259 shares of the medical instruments supplier's stock, valued at approximately $1,786,000. Los Angeles Capital Management LLC owned 0.39% of OraSure Technologies as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Raymond James & Associates purchased a new position in OraSure Technologies in the first quarter worth $158,000. Thrivent Financial for Lutherans lifted its stake in shares of OraSure Technologies by 54.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 116,231 shares of the medical instruments supplier's stock worth $560,000 after buying an additional 41,164 shares during the period. Freedom Wealth Alliance LLC acquired a new position in OraSure Technologies during the fourth quarter valued at $123,000. Factorial Partners LLC lifted its position in OraSure Technologies by 11.9% during the first quarter. Factorial Partners LLC now owns 169,000 shares of the medical instruments supplier's stock valued at $1,022,000 after purchasing an additional 18,000 shares during the period. Finally, Inspire Investing LLC acquired a new position in OraSure Technologies during the first quarter valued at $475,000. 85.06% of the stock is owned by hedge funds and other institutional investors.

NASDAQ:OSUR opened at $4.49 on Friday. The firm has a 50-day moving average price of $4.96 and a two-hundred day moving average price of $5.67. OraSure Technologies, Inc. has a twelve month low of $3.11 and a twelve month high of $7.82. The company has a market capitalization of $328.95 million, a P/E ratio of 11.51 and a beta of 0.08.

OraSure Technologies (NASDAQ:OSUR - Get Free Report) last released its earnings results on Wednesday, May 10th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.21. The firm had revenue of $154.96 million during the quarter, compared to the consensus estimate of $127.14 million. OraSure Technologies had a net margin of 6.16% and a return on equity of 12.66%. On average, equities research analysts predict that OraSure Technologies, Inc. will post 0.19 earnings per share for the current year.

A number of research analysts have weighed in on the stock. Stephens decreased their price objective on shares of OraSure Technologies from $6.50 to $5.00 in a research report on Monday, July 17th. StockNews.com cut shares of OraSure Technologies from a "buy" rating to a "hold" rating in a research note on Friday, July 7th. Finally, TheStreet raised shares of OraSure Technologies from a "d+" rating to a "c" rating in a research note on Wednesday, May 10th.

Check Out Our Latest Stock Analysis on OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider OraSure Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OraSure Technologies wasn't on the list.

While OraSure Technologies currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.